BACKGROUND: Surveillance imaging often shows indeterminate lesions in the cirrhotic liver, which may represent early hepatocellular carcinoma (HCC), dysplastic or regenerative nodules, or vascular shunts. The risk of HCC after identification of an indeterminate nodule is not well described. METHODS: We identified 252 patients with cirrhosis and at least one indeterminate nodule discovered on surveillance imaging over a 4-year period. The incidence of HCC development within 2 years of nodule identification was measured along with baseline risk factors associated with developing HCC. RESULTS: The incidence of HCC in this population was 21% (53 of 252), and risk factors associated with HCC included chronic viral hepatitis, male gender, and low platelet count. The median time from identification of an indeterminate nodule to diagnosis of HCC was 2.7 months. Patients with indeterminate nodules who developed HCC were more likely have to have an indeterminate nodule with arterial enhancement. CONCLUSIONS: The 2-year incidence of HCC in the setting of cirrhosis and an indeterminate nodule discovered by surveillance imaging may be as high as one in five persons. Early follow-up imaging, biopsy, or empiric treatment should be considered for those at higher risk. Further, this population is well suited for early detection biomarker and chemoprevention studies.
BACKGROUND: Surveillance imaging often shows indeterminate lesions in the cirrhotic liver, which may represent early hepatocellular carcinoma (HCC), dysplastic or regenerative nodules, or vascular shunts. The risk of HCC after identification of an indeterminate nodule is not well described. METHODS: We identified 252 patients with cirrhosis and at least one indeterminate nodule discovered on surveillance imaging over a 4-year period. The incidence of HCC development within 2 years of nodule identification was measured along with baseline risk factors associated with developing HCC. RESULTS: The incidence of HCC in this population was 21% (53 of 252), and risk factors associated with HCC included chronic viral hepatitis, male gender, and low platelet count. The median time from identification of an indeterminate nodule to diagnosis of HCC was 2.7 months. Patients with indeterminate nodules who developed HCC were more likely have to have an indeterminate nodule with arterial enhancement. CONCLUSIONS: The 2-year incidence of HCC in the setting of cirrhosis and an indeterminate nodule discovered by surveillance imaging may be as high as one in five persons. Early follow-up imaging, biopsy, or empiric treatment should be considered for those at higher risk. Further, this population is well suited for early detection biomarker and chemoprevention studies.
Authors: Leonard B Seeff; Gregory T Everson; Timothy R Morgan; Teresa M Curto; William M Lee; Marc G Ghany; Mitchell L Shiffman; Robert J Fontana; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag Journal: Clin Gastroenterol Hepatol Date: 2010-04-01 Impact factor: 11.382
Authors: Shishir K Maithel; Peter J Kneuertz; David A Kooby; Charles R Scoggins; Sharon M Weber; Robert C G Martin; Kelly M McMasters; Clifford S Cho; Emily R Winslow; William C Wood; Charles A Staley Journal: J Am Coll Surg Date: 2011-04 Impact factor: 6.113
Authors: Robert D Mair; Antonia Valenzuela; Nghiem B Ha; Walid S Ayoub; Tami Daugherty; Glen A Lutchman; Gabriel Garcia; Aijaz Ahmed; Mindie H Nguyen Journal: Clin Gastroenterol Hepatol Date: 2012-08-16 Impact factor: 11.382
Authors: Eliza W Beal; Joseph F Kearney; Jeffery M Chakedis; A James Hanje; Lanla F Conteh; Sylvester M Black; Kenneth Washburn; Kristin M Dittmar; Timothy M Pawlik; Mary R Dillhoff; Carl R Schmidt Journal: J Gastrointest Surg Date: 2017-05-26 Impact factor: 3.452
Authors: Thomas G Bird; Polyxeni Dimitropoulou; Rebecca M Turner; Sara J Jenks; Pearce Cusack; Shiying Hey; Andrew Blunsum; Sarah Kelly; Catharine Sturgeon; Peter C Hayes; Sheila M Bird Journal: PLoS One Date: 2016-06-16 Impact factor: 3.240
Authors: Sara Cococcia; Priti Dutta; Melika Moghim; Brian Hogan; Sudeep Tanwar; Aileen Marshall; Douglas Macdonald; Dominic Yu; James O'Beirne; William M Rosenberg; Paul M Trembling Journal: BMC Gastroenterol Date: 2022-03-10 Impact factor: 3.067